Results 321 to 330 of about 31,411 (361)

Dissolution Behavior of Commercial Enteric-coated Aspirin Tablets

Journal of Pharmaceutical Sciences, 1979
Dissolution behavior was studied for four commercial batches of enteric-coated aspirin tablets from two companies. The USP XIX dissolution procedure was modified by including pretreatment in simulated gastric juice. The effects of five pretreatment times were studied.
Koral Embil, George Torosian
openaire   +3 more sources

Tableting and stability evaluation of enteric-coated omeprazole pellets

European Journal of Pharmaceutics and Biopharmaceutics, 2004
In this study, fluidized-bed manufactured enteric-coated omeprazole pellets were compressed into tablets. The stability of the pellets and those of compressed tablets were evaluated for remaining omeprazole and for degradation products under an accelerated stability protocol. The data were analyzed using the artificial neural network (ANN) and analysis
Murat Türkoğlu, Mine Çelikok, Hakan Varol   +2 more
openaire   +3 more sources

Gastric retention of enteric‐coated aspirin tablets in beagle dogs

Journal of Veterinary Pharmacology and Therapeutics, 1990
Nap, R.C., Breen, D.J., Lam, T.J.G.M. & de Bruyne, J.J. Gastric retention of enteric‐coated aspirin tablets in beagle dogs. J. vet. Pharmacol. Therap. 13, 148–153.Administration of acetylsalicyclic acid (ASA) in the dog may cause gastric mucosal damage. Enteric‐coated tablets protect the canine stomach during oral ASA medication.
D.J. Breen, Theo J.G.M. Lam, J J de Bruyne, R. C. Nap   +3 more
openaire   +4 more sources

Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets

European Journal of Gastroenterology & Hepatology, 2001
A patient who presented with upper abdominal pain, nausea and ascites together with peripheral eosinophilia is described. Based on a surgical full-thickness biopsy of the antrum, the diagnosis of eosinophilic gastroenteritis was made. Treatment with prednisone resulted in a clinical response, but the prednisone dose could not be lowered below 5 mg.
Tan, A., Kruimel, J.W., Naber, A.H.J.
openaire   +4 more sources

A time-scaled convolution approach to construct IVIVC for enteric-coated acetylsalicylic acid tablets.

Pharmazie, 2018
A scaled convolution-based in vitro-in vivo (IVIVC) model was constructed for two enteric-coated acetylsalicylic acid tablet formulations. The in vitro data used were the results of dissolution testing performed using three different dissolution methods:
J. Al-Gousous, P. Langguth
semanticscholar   +1 more source

Aspirin—A National Survey V: Determination of Aspirin and Impurities in Enteric Coated Tablets and Suppository Formulations and In Vitro Dissolution of Enteric Coated Tablets

Journal of Pharmaceutical Sciences, 1982
The results of a national survey on the quality of enteric coated aspirin tablets and aspirin suppositories are presented. The tablets were analyzed for strength, salicylic acid content, in vitro dissolution rate, and related aspirin impurities. The suppositories were analyzed for strength and salicylic acid content.
Paul E. Flinn, Ross D. Kirchhoefer, Everett H. Jefferson   +2 more
openaire   +3 more sources

Formulation and Development of Enteric Coated Tablet for Parkinson's Disease

Research Journal of Pharmacy and Technology, 2020
The current investigation is to formulate and develop enteric coated tablet of Ropinirole Hydrochloride. Enteric coated tablets were prepared by Wet Granulation method by using water as solvent. To protect drug from acid Eudragit L-100 was used as enteric coated polymer.
Rutuja R F, Rajkumar V. Shete, Ravindra A Dhawale, Rahul S. Solunke, K J Kore, Madhuri T. Deshmukh   +5 more
openaire   +2 more sources

Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack.

AAPS PharmSciTech
Mesalamine is a locally acting anti-inflammatory drug used to treat mild to moderate ulcerative colitis. Because of complex formulation principle and high in vivo variability, development of bioequivalent formulation for mesalamine is challenging ...
Sivacharan Kollipara, Pankaj Kumar Prabhat, Paramita Saha, Saurabh Gupta, Venkat Ramana Naidu, Tausif Ahmed   +5 more
semanticscholar   +1 more source

Tolerance of Didanosine as Enteric-Coated Capsules versus Buffered Tablets

AIDS Patient Care and STDs, 2004
329 E Didanosine (ddI) is a nucleoside analogue that competitively inhibits the HIV reverse transcriptase enzyme. The lability of the molecule in acid milieu reduces its bioavailability to 10% when administered orally.1 A first approach to overcome this limitation was the formulation of ddI as buffered tablets, so that the absorption of the drug was ...
Pablo Barreiro, Vincent Soriano, Marina Núñez, Arturo Corbatón, Juan González-Lahoz   +4 more
openaire   +3 more sources

Pharmacomagnetography to evaluate the performance of magnetic enteric-coated tablets in the human gastrointestinal tract.

European journal of pharmaceutics and biopharmaceutics, 2021
Leonardo Antonio Pinto, Luciana Aparecida Corá, Gustavo Serafim Rodrigues, Andre Gonçalves Prospero, Guilherme Augusto Soares, U. de Andreis, José Ricardo de Arruda Miranda   +6 more
semanticscholar   +1 more source